Original Research
Published on 12 Nov 2024
Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
![Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis](https://www.frontiersin.org/files/myhome article library/1480676/1480676_Thumb_400.jpg)
- 1,730 views
Original Research
Published on 12 Nov 2024
in Multiple Sclerosis and Neuroimmunology
Case Report
Published on 07 Nov 2024
in Multiple Sclerosis and Neuroimmunology
Case Report
Published on 06 Nov 2024
in Multiple Sclerosis and Neuroimmunology
Editorial
Published on 01 Nov 2024
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 01 Nov 2024
in Multiple Sclerosis and Neuroimmunology
General Commentary
Published on 23 Oct 2024
in Multiple Sclerosis and Neuroimmunology
Case Report
Published on 22 Oct 2024
in Multiple Sclerosis and Neuroimmunology
Perspective
Published on 22 Oct 2024
in Multiple Sclerosis and Neuroimmunology
Brief Research Report
Published on 18 Oct 2024
in Multiple Sclerosis and Neuroimmunology
Review
Published on 18 Oct 2024
in Multiple Sclerosis and Neuroimmunology
Correction
Published on 17 Oct 2024
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 14 Oct 2024
in Multiple Sclerosis and Neuroimmunology
Case Report
Published on 11 Oct 2024
in Multiple Sclerosis and Neuroimmunology
Case Report
Published on 11 Oct 2024
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 07 Oct 2024
in Multiple Sclerosis and Neuroimmunology
Case Report
Published on 03 Oct 2024
in Multiple Sclerosis and Neuroimmunology